发明名称 |
Antitumor agent using compounds having kinase inhibitory effect in combination |
摘要 |
<p>Disclosed is an antitumor agent which uses a compound represented by formula (I) or a pharmacologically acceptable salt thereof in combination with a compound represented by formula (II) or a pharmacologically acceptable salt thereof. The antitumor agent exhibits remarkable antitumor effect in comparison to the cases where each one of the above-mentioned compounds is used alone. In addition, the antitumor agent exhibits antitumor effect on various kinds of cancer. (In the formulae, R</p> |
申请公布号 |
AU2011270165(B2) |
申请公布日期 |
2015.12.24 |
申请号 |
AU20110270165 |
申请日期 |
2011.06.23 |
申请人 |
EISAI R&D MANAGEMENT CO., LTD. |
发明人 |
NAKAGAWA, TAKAYUKI;MATSUSHIMA, TOMOHIRO;FUNAHASHI, YASUHIRO |
分类号 |
A61K31/4427;A61K31/4545;A61K31/47;A61K31/496;A61P35/00 |
主分类号 |
A61K31/4427 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|